Target intelligence / Profile preview

Flavivirus pre-membrane protein M (prM protein, sometimes abbreviated as prM/M or M protein in mature virions)

Target
prM protein, sometimes abbreviated as prM/M or M protein in mature virions
Molecular classification
Viral structural protein, Envelope-associated protein, Other (not a typical mammalian receptor, enzyme, or ion channel)
01

Overview

The Flavivirus pre-membrane protein M (prM protein) is a structural protein produced by cleavage of the viral polyprotein in the endoplasmic reticulum of infected cells. In immature virions, prM forms heterodimers with the envelope E protein, acting as a chaperone to ensure correct folding and to mask the fusion peptide of E, thereby preventing premature activation of membrane fusion. Upon passage through the secretory pathway, prM is cleaved by the host protease furin, releasing the pr fragment and leaving the M protein, which helps stabilize the mature, fusion-competent structure of the virion. The prM/E interface and its processing are critical for infectivity, and both the prM protein and its remnants are major targets in vaccine development and antibody therapeutics. Disruption or misregulation of prM cleavage can result in the production of non-infectious or fusion-inactive virus particles. The prM protein is also implicated in pathogenic processes such as antibody-dependent enhancement, making its accurate inclusion and targeting essential for safe vaccine strategies.

Other names
Pre-membrane proteinprM proteinM protein (after furin cleavage/maturation)pr peptide (the cleaved N-terminal fragment)
02

Mechanism of action

Block maturation—Interfere with prM-E heterodimer formation or furin-mediated cleavage to prevent infectious virus formation. Prevent fusion—Stabilize prM-E interaction, preventing structural rearrangements necessary for membrane fusion. Induce immune response—Present prM/E epitopes in vaccine formulations for protective immunity.

03

Biological functions

Virus assembly—Integrates into the viral envelope during assemblyChaperone/folding—Ensures correct folding/maturation of the envelope E proteinPrevention of premature fusion—Covers E protein fusion peptide and blocks fusion in acidic compartments until appropriate maturationFacilitates infectivity—Contributes to surface morphology and membrane fusion capability of infectious virions
04

Disease associations

Infection—Essential for the infectivity and pathogenesis of flaviviruses (e.g., Dengue, Zika, Yellow fever, Japanese encephalitis virus)Other—Can act as an antigen in immune response and vaccine development
05

Safety considerations

Antibody-dependent enhancement (ADE)—prM can be targeted by non-neutralizing antibodies which may facilitate viral uptake and worsen disease, particularly with Dengue virusVaccine design challenges—Correct presentation and processing of prM essential for eliciting safe and effective immunity
06

Interacting drugs

Vaccine antigens—Recombinant prM/E complexes used in vaccine designs (e.g., CYD-TDV for Dengue, ChinZIKV for Zika)

2 more in the full profile.

07

Biomarkers

prM antigen—Used to monitor viral maturation and infection status in research assaysprM/E antibody levels—Used in vaccine development and serological studiesNo established clinical biomarkers for patient selection or efficacy monitoring in therapy.

Beyond the preview

Go deeper on Flavivirus pre-membrane protein M (prM protein, sometimes abbreviated as prM/M or M protein in mature virions).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Flavivirus pre-membrane protein M (prM protein, sometimes abbreviated as prM/M or M protein in mature virions).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call